Home All Products Ozempic 0.5 Mg Injection

Ozempic 0.5 Mg Injection

$135

Ozempic 0.5 mg Injection is a prescription injectable medicine containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is designed to support blood glucose control by enhancing glucose-dependent insulin secretion, reducing exceRead More

Send Inquiry

View Contact Details
Contact Details
Rx Pharmaceuticals

3316 E Richert AveFresno, CA 93726, USA

+1-3176756380

rxpharmaceuticals@yahoo.com


Product Specifications

  • Active Ingredient:

    Semaglutide

  • Dosage Strength:

    0.5 Mg

  • Drug Class:

    GLP-1 Receptor Agonist

  • Product Type:

    Injectable Medication

Description

Product Description

Ozempic 0.5 mg Injection is a prescription injectable medicine containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is designed to support blood glucose control by enhancing glucose-dependent insulin secretion, reducing excess glucagon release, and slowing gastric emptying, thereby contributing to improved metabolic regulation. This formulation is widely used in clinical practice for the management of type 2 diabetes mellitus, alongside diet and lifestyle modifications. Ozempic is supplied as a prefilled injection pen for convenient and accurate administration under medical guidance.


Key Features



  • Active ingredient: Semaglutide (GLP-1 receptor agonist)

  • Strength: 0.5 mg per dose

  • Long-acting injectable formulation

  • Prefilled pen for ease of use and dosing accuracy

  • Intended for prescription and clinical use

Product Specifications
Active Ingredient Semaglutide
Dosage Strength 0.5 mg
Drug Class GLP-1 receptor agonist
Product Type Injectable medication
Mechanism Stimulates insulin secretion
Primary Use Type 2 diabetes management
Secondary Use Weight management
Administration Subcutaneous injection
Frequency Once weekly
Form Prefilled injection pen
Target System Endocrine
Manufacturer Novo Nordisk
Storage Refrigerated
Regulatory Status Prescription medication
Shelf Life 24 months
Packaging Multi-dose pen
Molecular Type Peptide analogue
Solubility Injectable solution
Country Of Origin Canada
Product Specifications
Active Ingredient Semaglutide
Dosage Strength 0.5 mg
Drug Class GLP-1 receptor agonist
Product Type Injectable medication
Mechanism Stimulates insulin secretion
Primary Use Type 2 diabetes management
Secondary Use Weight management
Administration Subcutaneous injection
Frequency Once weekly
Form Prefilled injection pen
Target System Endocrine
Manufacturer Novo Nordisk
Storage Refrigerated
Regulatory Status Prescription medication
Shelf Life 24 months
Packaging Multi-dose pen
Molecular Type Peptide analogue
Solubility Injectable solution
Country Of Origin Canada
Share
Home
All Products
Search
Contact
Need Help?

3316 E Richert AveFresno, CA 93726, USA

GET DIRECTION
Send Inquiry